{"id":4239,"date":"2018-04-27T22:11:40","date_gmt":"2018-04-28T02:11:40","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4239"},"modified":"2018-04-27T22:11:46","modified_gmt":"2018-04-28T02:11:46","slug":"ipo-pipeline-update-week-ending-4-27-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-week-ending-4-27-18\/","title":{"rendered":"IPO Pipeline Update &#8211; Week Ending 4.27.18"},"content":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 61 active IPOs in the pipeline as of April 27, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong>in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/04\/Screen-Shot-2018-04-27-at-10.10.19-PM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-4240\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/04\/Screen-Shot-2018-04-27-at-10.10.19-PM.png\" alt=\"Screen Shot 2018-04-27 at 10.10.19 PM\" width=\"478\" height=\"309\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/04\/Screen-Shot-2018-04-27-at-10.10.19-PM.png 478w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/04\/Screen-Shot-2018-04-27-at-10.10.19-PM-300x194.png 300w\" sizes=\"(max-width: 478px) 100vw, 478px\" \/><\/a><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>Company: The Lovesac Company<br \/>\nSymbol: LOVE<br \/>\nDescription: They are a technology driven, omni-channel company that designs, manufactures and sells unique, high quality furniture comprised of modular couches called Sactionals and premium foam beanbag chairs called Sacs.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Roth Capital Partners<br \/>\nFiled: 4-20-18<br \/>\nListed Cash Raise: $46m<\/p>\n<p>Company: MR2 Group, Inc.<br \/>\nSymbol: MRMR<br \/>\nDescription: They are an intelligence empowered holding company that operates through our subsidiary, Precision Opinion, a full-service information research consulting firm with expertise in data-collection, research and analytics that commenced operations in 1996.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): ThinkEquity<br \/>\nFiled: 4-25-18<br \/>\nListed Cash Raise: $17.25m<\/p>\n<p>Company: EVO Payments, Inc.<br \/>\nSymbol: EVOP<br \/>\nDescription: They are a global merchant acquirer and payment processor servicing approximately 525,000 merchants in North America and Europe and processing more than 900 million transactions in North America and 1.7 billion transactions in Europe annually.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Citigroup, Deutsche Bank Securities, SunTrust Robinson Humphrey, Barclays, Cowen and Company, Goldman Sachs &amp; Co., Regions Securities LLC, William Blair<br \/>\nFiled: 4-25-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Scholar Rock Holding Corporation<br \/>\nSymbol: SRRK<br \/>\nDescription: They are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Jefferies, Cowen, BMO Capital<br \/>\nCo-Manager(s): Wedbush PacGrow<br \/>\nFiled: 4-27-18<br \/>\nListed Cash Raise: $75m<\/p>\n<p>Company: Kiniksa Pharmaceuticals, Ltd.<br \/>\nSymbol: KNSA<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Goldman Sachs, J.P. Morgan<br \/>\nCo-Manager(s): JMP Securities, Wedbush PacGrow<br \/>\nFiled: 4-27-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: GreenSky, Inc.<br \/>\nSymbol: GKSY<br \/>\nDescription: They are a leading technology company that powers commerce at the point of sale.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Goldman Sachs &amp; Co., J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Citigroup, Credit Suisse, SunTrust Robinson Humphreu<br \/>\nCo-Manager(s): Raymond James, Sandler O&#8217; Neill, Fifth Third Securities, Guggenheim Securities<br \/>\nFiled: 4-27-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><\/p>\n<p>Company: Construction Partners, Inc.<br \/>\nSymbol: ROAD<br \/>\nDescription: They are one of the fastest growing civil infrastructure companies in the United States specializing in the building and maintenance of transportation networks.<br \/>\nTrade Date: 5\/4<br \/>\nShares: 11.3 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s): Baird, Raymond James, Stephens Inc<br \/>\nCo-Manager(s): Imperial Capital, D.A. Davidson &amp; Co.<br \/>\nTerms Added: 4-23-18<\/p>\n<p>Company: Inspire Medical Systems, Inc.<br \/>\nSymbol: INSP<br \/>\nDescription: They are a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea.<br \/>\nTrade Date: 5\/3<br \/>\nShares: 5 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): BofA Merrill Lynch, Goldman Sachs &amp; Co.<br \/>\nCo-Manager(s): Guggenheim Securities, Stifel, Wells Fargo Securities<br \/>\nTerms Added: 4-23-18<\/p>\n<p>Company: PermRock Royalty Trust<br \/>\nSymbol: PRT<br \/>\nDescription: They are a Delaware statutory trust formed in November 2017 by Boaz Energy, a portfolio company of NGP that is focused on the acquisition, development and operation of oil and natural gas properties in the Permian Basin.<br \/>\nTrade Date: 5\/2<br \/>\nShares: 6.25 million<br \/>\nPrice Range: $19.00-$21.00<br \/>\nUnderwriter(s): Wells Fargo Securities, Goldman Sachs &amp; Co., UBS Investment Bank, Deutsche Bank, Jefferies, Stifel, Oppenheimer &amp; Co.<br \/>\nCo-Manager(s): BB&amp;T Capital, Janney Montgomery Scott<br \/>\nTerms Added: 4-23-18<\/p>\n<p>Company: Carbon Black, Inc.<br \/>\nSymbol: CBLK<br \/>\nDescription: They are a leading provider of next-generation endpoint security solutions.<br \/>\nTrade Date: 5\/4<br \/>\nShares: 8 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s): Morgan Stanley, J.P. Morgan<br \/>\nCo-Manager(s): KeyBanc Capital, William Blair, Raymond James, Cowen<br \/>\nTerms Added: 4-23-18<\/p>\n<p>Company: Unity Biotechnology, Inc.<br \/>\nSymbol: UBX<br \/>\nDescription: They are looking to develop a broad portfolio of drug candidates to treat the diseases of aging, and they plan to initiate their first clinical study of their lead drug candidate in the first half of 2018.<br \/>\nTrade Date: 5\/3<br \/>\nShares: 5 million<br \/>\nPrice Range: $16.00-$18.00<br \/>\nUnderwriter(s): Goldman Sachs &amp; Co., Morgan Stanley, Citigroup<br \/>\nCo-Manager(s): Mizuho Securities<br \/>\nTerms Added: 4-23-18<\/p>\n<p>Company: AXA Equitable Holdings, Inc.<br \/>\nSymbol: EQH<br \/>\nDescription: They are one of America\u2019s leading financial services companies and have helped clients prepare for their financial future with confidence since 1859.<br \/>\nTrade Date: 5\/10<br \/>\nShares: 137.3 million<br \/>\nPrice Range: $24.00-$27.00<br \/>\nUnderwriter(s): Morgan Stanley, J.P. Morgan, Barclays, Citigroup. BofA Merrill Lynch, Credit Suisse, Deutsche Bank Securities, Goldman Sachs &amp; Co. BNP PARIBAS, SOCIETE GENERALE, ING, Credit Agricole CIB, HSBC, Natixis, RBC Capital Markets<br \/>\nCo-Manager(s): Lazard, BBVA, COMMERZBANK, Mizuho Securities, MUFG, PNC Capital Markets LLC, SMBC Nikko, SunTrust Robinson Humphrey, UniCredit Capital Markets<br \/>\nTerms Added: 4-26-18<\/p>\n<p>Company: Origin Bancorp, Inc.<br \/>\nSymbol: OBNK<br \/>\nDescription: They are a financial holding company headquartered in Ruston, Louisiana.<br \/>\nTrade Date: 5\/9<br \/>\nShares: 3.6 million<br \/>\nPrice Range: $33.00-$35.00<br \/>\nUnderwriter(s): Stephens Inc. Raymond James<br \/>\nCo-Manager(s): Keefe Bruyette &amp; Woods, Sandler O\u2019 Neill<br \/>\nTerms Added: 4-27-18<\/p>\n<p>Company: BayCom Corp<br \/>\nSymbol: BCML<br \/>\nDescription: They are a bank holding company headquartered in Walnut Creek, California.<br \/>\nTrade Date: 5\/4<br \/>\nShares: 2.27 million<br \/>\nPrice Range: $21.00-$23.00<br \/>\nUnderwriter(s): FIG Partners, D.A. Davidson<br \/>\nTerms Added: 4-27-18<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 61 active IPOs in the pipeline as of April 27, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: The[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-4239","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4239"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4239\/revisions"}],"predecessor-version":[{"id":4241,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4239\/revisions\/4241"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}